Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | PLK1 | P53350 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.40 |
| ▸ | TYR | P14679 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10979679 | 0.86 | THRA (0.44) | ALOX5PLK1TSHRS1PR2S1PR4 | |
| SCHEMBL27750960 | 0.81 | NPC1 (0.41) | SRCENPP2PLK1CYP3A4HTT | |
| SCHEMBL11619328 | 0.81 | GAA (0.41) | ALOX5ENPP2PLK1TYRMEN1 | |
| SCHEMBL3683527 | 0.81 | GAA (0.41) | ALOX5ENPP2PLK1TYRMEN1 | |
| SCHEMBL11619330 | 0.78 | LIPG (0.46) | ALOX5ENPP2PLK1S1PR2S1PR4 | |
| SCHEMBL8461311 | 0.76 | PLK1 (0.35) | SRCALOX5ENPP2PLK1LPAR3 | |
| SCHEMBL8852795 | 0.76 | PLK1 (0.35) | SRCALOX5ENPP2PLK1LPAR3 | |
| SCHEMBL29174980 | 0.76 | TYR (0.45) | ALOX5ENPP2PLK1LPAR3LPAR1 | |
| SCHEMBL29045393 | 0.76 | TYR (0.45) | ALOX5ENPP2PLK1LPAR3LPAR1 | |
| SCHEMBL6318720 | 0.76 | NPC1 (0.37) | SRCENPP2PLK1CYP3A4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149661-A1 | POLYCARBONATE COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-06-28 | — | — | US | claimed |
| US-12570848-B2 | Scratch-resistant high impact strength PMMA compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-03-10 | — | — | US | disclosed |
| US-12403437-B2 | Method for producing nanodiamonds doped with group 14 element, and method for purifying same | DAICEL CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| US-12351463-B2 | Heteroatom-doped nanodiamond | DAICEL CORPORATION (JP) | 2025-07-08 | — | — | US | disclosed |
| EP-4172269-B1 | THERMOPLASTIC COMPOSITIONS WITH IMPROVED HYDROLYTIC AND HEAT STABILITY | SHPP GLOBAL TECH BV (NL) | 2025-05-28 | — | — | EP | disclosed |
| WO-2025104593-A1 | PFAS-FREE FLAME RETARDANT, IMPACT RESISTANT AND CHEMICAL RESISTANT POLYCARBONATE COMPOSITIONS | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-05-22 | — | — | WO | disclosed |
| US-20250002355-A1 | HETEROATOM-DOPED NANODIAMOND PARTICLES AND METHOD FOR PRODUCING HETEROATOM-DOPED NANODIAMOND PARTICLES | DAICEL CORPORATION (JP) | 2025-01-02 | — | — | US | disclosed |
| WO-2024219059-A1 | NV CENTER-CONTAINING NANODIAMOND PARTICLE AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2024-10-24 | — | — | WO | disclosed |
| EP-3390469-B1 | METHOD FOR ISOMER REDUCTION DURING POLYMERIZATION AND SYSTEM FOR ACCOMPLISHING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4382481-A1 | HETEROATOM-DOPED NANODIAMOND PARTICLES AND METHOD FOR PRODUCING HETEROATOM-DOPED NANODIAMOND PARTICLES | Daicel Corporation (JP) | 2024-06-12 | — | — | EP | disclosed |
| EP-0055473-A1 | Resin compositions | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-07 | — | — | EP | disclosed |
| EP-0043838-A4 | POLYPHENYLENE OXIDE/PLASTICIZER/HYDROGENATED RADIAL TELEBLOCK COPOLYMER BLENDS. | GEN ELECTRIC (US) | 1982-04-29 | — | — | EP | disclosed |
| US-4313864-A | IMPACT RESISTANCE | GENERAL ELECTRIC COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| EP-0043838-A1 | POLYPHENYLENE OXIDE/PLASTICIZER/HYDROGENATED RADIAL TELEBLOCK COPOLYMER BLENDS | GENERAL ELECTRIC COMPANY (US) | 1982-01-20 | — | — | EP | disclosed |
| WO-1981002160-A1 | POLYPHENYLENE OXIDE/PLASTICIZER/HYDROGENATED RADIAL TELEBLOCK COPOLYMER BLENDS | GEN ELECTRIC (US) | 1981-08-06 | — | — | WO | disclosed |
| US-4254011-A | CONTAINING A TWO-PHASE CROSSLINKED POLYACRYLATE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-03 | — | — | US | disclosed |
| US-4154712-A | VINYLAROMATIC-CONJUGATED DIENE BLOCK POLYMER | GENERAL ELECTRIC COMPANY (US) | 1979-05-15 | — | — | US | disclosed |
| US-4136089-A | 2,2-DIETHYL-PROPANE-1,3-DIOL | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4107149-A | Poly(ethylene/alkylene) terephthalates which crystallize rapidly | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-15 | — | — | US | disclosed |
| US-4086212-A | ESTERIFICATION OR TRANSESTERIFICATION | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570848-B2 | Scratch-resistant high impact strength PMMA compositions | PCNA, COL2A1, COL1A1 | SRC 1022/4885ALOX5 3823/4885ENPP2 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.